The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription

Oncogene

Volumn 22, Issue 32, 2003, Pages 4973-4982

  Cutress, Ramsey I ^a   Townsend, Paul A ^a,d   Sharp, Adam ^a   Maison, Anna ^b   Wood, Lynn ^a   Lee, Ron ^b   Brimmell, Matthew ^a   Mullee, Mark A ^a   Johnson, Peter W M ^a   Royle, Gavin T ^c   Bateman, Adrian C ^b   Packham, Graham ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BAG 1; Breast cancer; Hormone therapy; Oestrogen; Receptor; Survival

Indexed keywords

BAG 1 PROTEIN; CELL PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEAT SHOCK PROTEIN; HORMONE RECEPTOR; ISOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN BAG 1L; PROTEIN BAG 1M; PROTEIN BAG 1S; UNCLASSIFIED DRUG; BCL2 ASSOCIATED ATHANOGENE 1 PROTEIN; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; BREAST TUMOR; CELL SURVIVAL; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; SERODIAGNOSIS;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL SURVIVAL; DNA-BINDING PROTEINS; ESTROGENS; FEMALE; HUMANS; PRECIPITIN TESTS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0041783921     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206688     Document Type: Article

References (52)

1. American Society of Clinical Oncology (1996). J. Clin. Oncol., 14, 2843-2877.
2. Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C and Comoglio PM. (1996). EMBO J, 15, 6205-6212.
3. Bloom HJG and Richardson WW. (1957). Br. J. Cancer, 1957, 359-377.
4. Briknarova K, Takayama S, Brive L, Havert ML, Knee DA, Velasco J, Homma S, Cabezas E, Stuart J, Hoyt DW, Satterthwait AC, Llinas M, Reed JC and Ely KR. (2001). Nat. Struct. Biol., 8, 349-352.
5. Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR and Packham G. (1999). Br. J. Cancer, 81, 1042-1051.
6. Cato AC and Mink S. (2001). J. Steroid Biochem. Mol. Biol., 78, 379-388.
7. Cheung J and Smith DF. (2000). Mol Endocrinol., 14, 939-946.
8. Clemons M and Goss P. (2001). N. Engl. J. Med., 344, 276-285.
9. Clevenger CV, Thickman K, Ngo W, Chang WP, Takayama S and Reed JC. (1997). Mol. Endocrinol., 11, 608-618.
10. Colditz GA, (1998). J. Natl. Cancer Inst., 90, 814-823.
11. Coldwell MJ, deSchoolmeester ML, Fraser GA, Pickering BM, Packham G and Willis AE. (2001). Oncogene, 20, 4095-4100.
12. Cutress RI, Townsend PA, Bateman AC, Johnson PW, Ryder K, Barnes DM and Packham G. (2001). J. Clin Oncol., 19, 3706-3707.
13. Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A and Packham G. (2002). Bri. J. Cancer, 87, 834-839.
14. Dickson RB and Stancel GM. (2000). J. Natl. Cancer Inst. Monogr., 27, 135-145.
15. Early Breast Cancer Trialists' Collaborative Group. (1998). Lancet. 351, 1451-1467.
16. Elston CW and Ellis IO. (1991). Histopathology, 19, 403-410.
17. Foster JS, Henley DC, Ahamed S and Wimalasena J. (2001). Trends Endocrinol Metabol., 12, 320-327.
18. Froesch BA, Takayama S and Reed JC. (1998). J. Biol. Chem., 273, 11660-11666.
19. Guzey M, Takayama S and Reed JC. (2000). J. Biol. Chem., 275, 40749-40756.
20. Hague A, Packham G, Huntley S, Shefford K and Eveson JW. (2002). J. Pathol., 197, 60-71.
21. Hohfeld J. (1998). Biol. Chem., 379, 269-274.
22. Horwitz KB, Koseki Y and McGuire WL. (1978). Endocrinology, 103, 1742-1751.
23. Horowitz KB and McGuire WL. (1975). Science, 189, 726-727.
24. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS and McCarty Jr KS. (1989). Cancer Res, 49, 1052-1056.
25. Knee DA, Froesch BA, Nuber U, Takayama S and Reed JC. (2001). J. Biol. Chem., 276, 12718-12724.
26. Kudoh M, Knee DA, Takayama S and Reed JC. (2002). Cancer Res., 62, 1904-1909.
27. Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U and Cato AC. (1998). J. Biol. Chem., 273, 14620-14625.
28. Liu R, Takayama S, Zheng Y, Froesch B, Chen GQ, Zhang X, Reed JC and Zhang XK. (1998). J. Biol. Chem., 273, 16985-16992.
29. Mandlekar S and Kong A-NT. (2001). Apoptosis, 6, 469-477.
30. Niyaz Y, Zeiner M and Gehring U. (2001). J. Cell Sci., 114, 10-45.
31. Pace P, Taylor J, Suntharalingam S, Coombes RC and Ali S. (1997). J. Biol. Chem., 272, 25832-25838.
32. Packham G, Brimmell M and Cleveland JL. (1997). Biochem. J., 328, 807-813.
33. Pratt WB and Toft DO. (1997). Endocrine Rev., 18, 306-360.
34. Rorke S, Murphy S, Khalifa M, Chernenko G and Tang SC. (2001). Int. J. Cancer, 95, 317-322.
35. Schulz JB, Bremen D, Reed JC, Lommatzsch J, Takayama S, Wullner U, Loschmann PA, Klockgether T and Weller M. (1997). J. Neurochem., 69, 2075-2086.
36. Shindoh M, Adachi M, Higashino F, Yasuda M, Hida K, Nishioka T, Ono M, Takayama S, Reed JC, Imai K, Totsuka Y and Kohgo T. (2000). Oral Oncol., 36, 444-449.
37. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K. (1997). Oncogene, 14, 2971-2977.
38. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, Scudiero D, Tudor G, Miller GJ, Miyashita T, Yamada M and Reed JC. (1998). Cancer Res., 58, 3116-3131.
39. Takayama S and Reed J. (2001). Nat. Cell Biol., 3, 237-241.
40. Tang SC, Shaheta N, Chernenko G, Khalifa M and Wang X. (1999). J. Clin. Oncol., 17, 1710-1719.
41. Townsend PA, Dublin E, Hart IR, Kao R-H, Hanby AM, Cutress RI, Poulsom R, Ryder K, Barnes DM and Packham G. (2002). J. Pathol., 197, 51-59.
42. Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, Rebbeck TR, Haffty BG and Reed JC. (2001). J. Clin. Oncol., 19, 992-1000.
43. Wang HG, Takayama S, Rapp UR and Reed JC. (1996). Proc. Natl. Acad. Sci. USA, 93, 7063-7068.
44. Witcher M, Yang X, Pater A and Tang SC. (2001). Exp. Cell Res., 265, 167-173.
45. Yamauchi H, Adachi M, Sakata K, Hareyama M, Satoh M, Himi T, Takayama S, Reed JC and Imai K. (2001). Cancer Lett., 165, 103-110.
46. Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A and Tang SC. (1998). Oncogene, 17, 981-989.
47. Yang X, Hao Y, Ding Z, Pater A and Tang SC. (1999a). Clin. Cancer Res., 5, 1816-1822.
48. Yang X, Hao Y, Ferenczy A, Tang SC and Pater A. (1999b). Exp. Cell Res., 247, 200-207.
49. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K. (1998). Oncogene, 16, 2681-2686.
50. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E and Reed JC. (1998). Breast Cancer Res. Treat., 47, 129-140.
51. Zeiner M and Gehring U. (1995). Proc. Natl. Acad. Sci. USA, 92, 11465-11469.
52. Zeiner M, Niyaz Y and Gehring U. (1999). Proc. Natl. Acad. Sci. USA, 96, 10194-10199.